Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion. - Wikidata - awgldk - TriplyDB

Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

http://www.wikidata.org/entity/Q34558670

about

11q deletion in neuroblastoma: a review of biological and clinical implications.Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells.The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.Diagnostic implications of intrapatient genetic tumor heterogeneity.Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors.Lymph microvascularization as a prognostic indicator in neuroblastoma.

P2860

Q32174267-5B0715E1-BCB8-4843-8DB6-819D1FA39735 Q34032495-40A8E298-C4E8-42E1-B329-40DD14563983 Q34346730-CAED103C-E99C-465E-A953-3501583C1DBC Q35416653-DB9C8D29-3A65-4BEE-845F-4329A573313C Q37105296-867D2D04-AA21-4823-A98D-446848DC87CD Q37731564-8D6D14E5-7C7A-4D00-89D5-A5197B43034C Q38768383-7D8CF886-4623-4771-9ADC-41A58BB8E9E4 Q38831708-26A11834-7742-45C6-8B6F-781A82BF3F41 Q38947597-6DEEACAC-27A6-498A-A209-4C090EC3CAA9 Q39064490-3CCBA1EB-9CD3-4957-A7C7-5A5C45610505 Q42252770-DB316B3D-7F67-43E0-84B0-FD521A620A48 Q50853134-AB2A33E1-8477-4539-828E-AA1518C1661C Q55241229-E2507C47-200C-4980-8EB4-88354030CA3B

P2860

Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

http://www.wikidata.org/entity/Q34558670

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Genetic instability and intrat ...... plification plus 11q deletion.

@ast

Genetic instability and intrat ...... plification plus 11q deletion.

@en

Genetic instability and intrat ...... plification plus 11q deletion.

@nl

type

label

Genetic instability and intrat ...... plification plus 11q deletion.

@ast

Genetic instability and intrat ...... plification plus 11q deletion.

@en

Genetic instability and intrat ...... plification plus 11q deletion.

@nl

prefLabel

Genetic instability and intrat ...... plification plus 11q deletion.

@ast

Genetic instability and intrat ...... plification plus 11q deletion.

@en

Genetic instability and intrat ...... plification plus 11q deletion.

@nl

P1433

Q34558670-B17802D2-0A65-4FB0-8405-DA240297D483

P1476

Q34558670-6BDF84B3-F9B3-4033-8D5C-8A612ADA50D7

P2093

Q34558670-0F1DC473-24F3-4647-8346-AE5DCBF41540

Q34558670-1E792ED2-18D9-449D-A2DA-4958954C408F

Q34558670-2343C285-C2CB-4746-B7CE-2FE83A574F4F

Q34558670-24CE858D-450A-408C-8B5B-4C2C14A4BF27

Q34558670-54DF9574-6A8F-47DC-8337-7B697DE9C14A

Q34558670-D7D4E0B1-9CC2-44F1-A0FD-9B728998267A

Q34558670-E699DEE7-D44E-4392-8D7C-E1D1EFFC06F9

P2860

Q34558670-020D8D04-DD85-45D0-9DD6-1F6F365E5DF5

Q34558670-1A061EDB-6102-4C10-89CE-158CA71878D6

Q34558670-1EECBC3A-AE1C-486C-88BC-9058D8E6DCEA

Q34558670-22599923-2D15-416E-B19C-89D0D923C864

Q34558670-2B5D65F2-F85D-4EC6-9DD5-2E42F53A5476

Q34558670-2E8AF94A-55B8-4419-87A0-E106EA74450A

Q34558670-35CE7C2D-1BC9-40DF-8B34-1E9A06CA81F9

Q34558670-386EC7EC-E054-4F1D-87DB-A5C498295A09

Q34558670-3D61A10F-C903-4899-8508-BCD75B6E1E30

Q34558670-41CF6B94-76A1-4240-A98F-858B3A2612C3

P304

Q34558670-E8438289-ACD0-4DEB-B3A7-A1BCAA5C24FF

P31

Q34558670-4C9BF560-D033-4D49-BF2B-1C2DD99C10F6

P356

Q34558670-824C60D6-EDA3-4248-8E0D-A4134FAD93BD

P407

Q34558670-079B2C68-9227-48EB-869F-E802FF2645FE

P433

Q34558670-B1B6B9E5-7124-45D0-BBB3-4430FA4FE8FE

P478

Q34558670-11D5CABD-5C15-4FAC-BE78-A4FDEC9018AC

P50

Q34558670-A41121FD-8449-4E6C-AAC0-53236EBA4EEF

Q34558670-D0D4FC41-FC0E-4720-856F-933206596A54

P577

Q34558670-2DE8075F-9131-40D4-AEEB-5D147110F031

P5875

Q34558670-E80DB83E-8C3F-4314-BFBC-4C4D020F1278

P698

Q34558670-33F58100-7E12-435B-9379-B1AB2FFC1718

P932

Q34558670-64CA18F7-E677-4882-9A3A-7828E8596456

P356

JOURNAL.PONE.0053740

P1433

P1476

Genetic instability and intrat ...... plification plus 11q deletion.

@en

P2093

Ana P Berbegall

http://www.w3.org/2001/XMLSchema#string

Anna Djos

http://www.w3.org/2001/XMLSchema#string

Eva Villamón

http://www.w3.org/2001/XMLSchema#string

Irene Tadeo

http://www.w3.org/2001/XMLSchema#string

Marta Piqueras

http://www.w3.org/2001/XMLSchema#string

Rosa Noguera

http://www.w3.org/2001/XMLSchema#string

Samuel Navarro

http://www.w3.org/2001/XMLSchema#string

P2860

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma

Neuroblastoma: biological insights into a clinical enigma.

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

P304

e53740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0053740

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Tommy Martinsson

Victoria Castel

P577

2013-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235364343

http://www.w3.org/2001/XMLSchema#string

P698

23341988

http://www.w3.org/2001/XMLSchema#string

P932

3544899

http://www.w3.org/2001/XMLSchema#string